Export 2751 results:
[ Author(Desc)] Title Type Year
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
B
R. W. Beck, Maguire, M. G., Bressler, N. M., Glassman, A. R., Lindblad, A. S., and Ferris, F. L., Visual acuity as an outcome measure in clinical trials of retinal diseases., Ophthalmology, vol. 114, no. 10, pp. 1804-9, 2007.
R. Beck, Maguire, M., Bressler, N., Glassman, A., Lindblad, A., and Ferris, F., Visual Acuity as an Outcome Measure in Clinical Trials of Retinal Diseases, Ophthalmology, vol. 114, pp. 1804-1809, 2007.
R. H. Behrens, Cramer, J. P., Jelinek, T., Shaw, H., von Sonnenburg, F., Wilbraham, D., Weinke, T., Bell, D. J., Asturias, E., Pauwells, H. L. Enkerlin, Maxwell, R., Paredes-Paredes, M., Glenn, G. M., Dewasthaly, S., Stablein, D. M., Jiang, Z. - D., and DuPont, H. L., Efficacy and safety of a patch vaccine containing heat-labile toxin from Escherichia coli against travellers' diarrhoea: a phase 3, randomised, double-blind, placebo-controlled field trial in travellers from Europe to Mexico and Guatemala., Lancet Infect Dis, vol. 14, no. 3, pp. 197-204, 2014.
J. H. Beigel, Tomashek, K. M., Dodd, L. E., Mehta, A. K., Zingman, B. S., Kalil, A. C., Hohmann, E., Chu, H. Y., Luetkemeyer, A., Kline, S., de Castilla, D. Lopez, Finberg, R. W., Dierberg, K., Tapson, V., Hsieh, L., Patterson, T. F., Paredes, R., Sweeney, D. A., Short, W. R., Touloumi, G., Lye, D. Chien, Ohmagari, N., Oh, M. - D., Ruiz-Palacios, G. M., Benfield, T., Fätkenheuer, G., Kortepeter, M. G., Atmar, R. L., C Creech, B., Lundgren, J., Babiker, A. G., Pett, S., Neaton, J. D., Burgess, T. H., Bonnett, T., Green, M., Makowski, M., Osinusi, A., Nayak, S., and H Lane, C., Remdesivir for the Treatment of Covid-19 - Preliminary Report., N Engl J Med, 2020.
M. D. Bellin, Barton, F. B., Heitman, A., Harmon, J. V., Kandaswamy, R., Balamurugan, A. N., Sutherland, D. E. R., Alejandro, R., and Hering, B. J., Potent induction immunotherapy promotes long-term insulin independence after islet transplantation in type 1 diabetes., Am J Transplant, vol. 12, no. 6, pp. 1576-83, 2012.
M. D. Bellin, Barton, F. B., Heitman, A., Harmon, J., Balamurugan, A. N., Kandaswamy, R., Sutherland, D. E., Alejandro, R., and Hering, B. J., Potent Induction Immunotherapy Promotes Long-Term Insulin Independence After Islet Transplantation in Type 1 Diabetes, Am J Transplant, vol. 12, pp. 1576-1583, 2012.
R. B. Belshe, Stevens, C., Gorse, G. J., Buchbinder, S., Weinhold, K., Sheppard, H., Stablein, D., Self, S., McNamara, J., Frey, S., Flores, J., Excler, J. L., Klein, M., Habib, R. E., Duliege, A. M., Harro, C., Corey, L., Keefer, M., Mulligan, M., Wright, P., Celum, C., Judson, F., Mayer, K., McKirnan, D., Marmor, M., and Woody, G., Safety and immunogenicity of a canarypox-vectored human immunodeficiency virus Type 1 vaccine with or without gp120: a phase 2 study in higher- and lower-risk volunteers., J Infect Dis, vol. 183, no. 9, pp. 1343-52, 2001.
R. B. Belshe, Mendelman, P. M., Treanor, J., King, J., Gruber, W., Piedra, P., Bernstein, D. I., Hayden, F. G., Kotloff, K., Zangwill, K., Iacuzio, I., and Wolff, M. C., The efficacy of live attenuated, cold adapted, trivalent, intranasal, influenza virus vaccine in children, N Engl J Med, vol. 338, pp. 1405-12, 1998.
R. B. Belshe, Newman, F. K., Wilkins, K., Graham, I. L., Babusis, E., Ewell, M., and Frey, S. E., Comparative Immunogenicity of Trivalent Influenza Vaccine Administered by Intradermal or Intramuscular Route in Healthy Adults, Vaccine, vol. 25, pp. 6755-6763, 2007.
R. B. Belshe, Gruber, W. C., Mendelman, P. M., Mehta, H. B., Mahmood, K., Reisinger, K., Treanor, J., Zangwill, K., Hayden, F. G., Bernstein, D. I., Kotloff, K., King, J., Piedra, P. A., Block, S. L., Yan, L., and Wolff, M., Correlates of immune protection induced by live, attenuated, cold-adapted, trivalent, intranasal influenza virus vaccine., J Infect Dis, vol. 181, no. 3, pp. 1133-7, 2000.
R. B. Belshe, Newman, F. K., Wilkins, K., Graham, I. L., Babusis, E., Ewell, M., and Frey, S. E., Comparative immunogenicity of trivalent influenza vaccine administered by intradermal or intramuscular route in healthy adults., Vaccine, vol. 25, no. 37-38, pp. 6755-63, 2007.
R. Belshe, Bolognesi, D., Clements, M., Corey, L., Fast, P., Graham, B., Keefer, M., Mestecky, J., Mulligan, M., Stablein, D., and Group, A. I. D. S. Vaccine Cl, Progress in HIV-1 Vaccine Development. Washington DC, 1995.
R. B. Belshe, Heineman, T. C., Bernstein, D. I., Bellamy, A. R., Ewell, M., van der Most, R., and Deal, C. D., Correlate of Immune Protection Against HSV-1 Genital Disease in Vaccinated Women, J Infect Dis, vol. 209, pp. 828-836, 2014.
R. B. Belshe, Heineman, T. C., Bernstein, D. I., Bellamy, A. R., Ewell, M., van der Most, R., and Deal, C. D., Correlate of immune protection against HSV-1 genital disease in vaccinated women., J Infect Dis, vol. 209, no. 6, pp. 828-36, 2014.
R. B. Belshe, Blevins, T. P., Yu, Y., Nethington, A. E., Bellamy, A., Bryant, C., and Morrison, L. A., Neutralizing Antibody Kinetics and Immune Protection Against Herpes Simplex Virus 1 Genital Disease in Vaccinated Women, J Infect Dis, vol. 227, no. 4, pp. 522-527, 2023.
R. B. Belshe, Stevens, C., Gorse, G. J., Buchbinder, S., Weinhold, K., Sheppard, H., Stablein, D., Self, S., McNamara, J., Frey, S., Flores, J., Excler, J. L., Klein, M., Habib, R. E., Duliege, A. M., Harro, C., Corey, L., Keefer, M., Mulligan, M., Wright, P., Celum, C., Judson, F., and , Safety and immunogenicity of a canarypox-vectored human immunodeficiency virus Type 1 vaccine with or without gp120: a phase 2 study in higher- and lower-risk volunteers, J Infec Dis, vol. 183, pp. 1343-52, 2001.
R. B. Belshe, Leone, P. A., Bernstein, D. I., Wald, A., Levin, M., Stapleton, J. T., Gorfinkel, I., Morrow, R. L., Ewell, M. G., Stokes-Riner, A., Dubin, G., Heineman, T. C., Schulte, J. M., Deal, C. D., and Women, H. Trial for, Efficacy Results of A Trial of A Herpes Simplex Vaccine, N Engl J Med, vol. 366, pp. 34-43, 2012.
R. B. Belshe, Newman, F. K., Frey, S. E., Couch, R. B., Treanor, J. J., Tacket, C. O., and Yan, L., Dose-dependent neutralizing-antibody responses to vaccinia., J Infect Dis, vol. 189, no. 3, pp. 493-7, 2004.
R. B. Belshe, Leone, P. A., Bernstein, D. I., Wald, A., Levin, M. J., Stapleton, J. T., Gorfinkel, I., Morrow, R. L. Ashley, Ewell, M. G., Stokes-Riner, A., Dubin, G., Heineman, T. C., Schulte, J. M., and Deal, C. D., Efficacy results of a trial of a herpes simplex vaccine., N Engl J Med, vol. 366, no. 1, pp. 34-43, 2012.
R. B. Belshe, Frey, S. E., Graham, I., Mulligan, M. J., Edupuganti, S., Jackson, L. A., Wald, A., Poland, G., Jacobson, R., Keyserling, H. L., Spearman, P., Hill, H., and Wolff, M., Safety and immunogenicity of influenza A H5 subunit vaccines: effect of vaccine schedule and antigenic variant., J Infect Dis, vol. 203, no. 5, pp. 666-73, 2011.
R. B. Belshe, Frey, S. E., Graham, I. L., Anderson, E. L., Jackson, L. A., Spearman, P., Edupuganti, S., Mulligan, M. J., Rouphael, N., Winokur, P., Dolor, R. J., Woods, C. W., Walter, E. B., Chen, W. H., Turley, C., Edwards, K. M., C Creech, B., Hill, H., and Bellamy, A. R., Immunogenicity of avian influenza A/Anhui/01/2005(H5N1) vaccine with MF59 adjuvant: a randomized clinical trial., JAMA, vol. 312, no. 14, pp. 1420-8, 2014.
B. R. Belshe, Gruber, W. C., Mendelman, P. M., Mehta, H. B., Cho, I., Mahmood, K., Reisinger, K., Treanor, J., Zangwill, K., Hayden, F. G., Bernstein, D. I., Kotloff, K., King, J., Piedra, P. A., Block, S. L., Yan, L., and Wolff, M., Correlates of immune protection induced by live, attenuated, cold-adapted, trivalent, intranasal influenza virus vaccine, J Infec Dis, vol. 181, pp. 11133-7, 2000.
R. B. Belshe, Mendelman, P. M., Treanor, J., King, J., Gruber, W. C., Piedra, P., Bernstein, D. I., Hayden, F. G., Kotloff, K., Zangwill, K., Iacuzio, D., and Wolff, M., The efficacy of live attenuated, cold-adapted, trivalent, intranasal influenzavirus vaccine in children., N Engl J Med, vol. 338, no. 20, pp. 1405-12, 1998.
R. B. Belshe, Frey, S. E., Graham, I. L., Anderson, E. L., Jackson, L. A., Spearman, P., Edupuganti, S., Mulligan, M. J., Rouphael, N., Winokur, P., Dolor, R. J., Woods, C. W., Walter, E. B., Chen, W. H., Turley, C., Edwards, K. M., Creech, C. B., Hill, H., and Bellamy, A. R., Immunogenicity of Avian Influenza A/Anhui/01/2005(H5N1) Vaccine with MF59 Adjuvant: A Randomized Clinical Trial, JAMA, vol. 312, pp. 1420-1428, 2014.
R. B. Belshe, Newman, F. K., Frey, S. E., Couch, R. B., Treanor, J. J., Tacket, C. O., and Yan, L., Dose-dependent neutralizing-antibody responses to vaccinia, Journal of Infectious Diseases, vol. 189, pp. 493-7, 2004.